Poland· PL-100087363
Betnovate C
A betamethason und antiseptika product containing betamethasoni valeras + clioquinolum, registered in Poland by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Betamethason und antiseptika is registered in 2 of 19 countries.
Countries holding a registration under ATC D07BC01 (betamethason und antiseptika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Betamethason und antiseptika · ATC D07BC01
2 / 19 countries
- Finlandprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Betamethasoni valeras + Clioquinolum
- Manufacturer
- GlaxoSmithKline Trading Services Limited
- Country
- Poland (PL)
- ATC code
- D07BC01
- ATC class
- Betamethason und Antiseptika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990423712
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Betamethason und antiseptika in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBetamethasone valerate 0.1% / Clioquinol 3% creamCST Pharma Ltd
- FinlandBemetson-KOrion Corporation Orion Pharma
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Bulgaria · Бетноват-С
- United Kingdom (Northern Ireland) · Betamethasone Valerate/Clioquinol Chemidex Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/77892b41-733e-4989-b66e-21ee577b4827 GET /v1/drugs/77892b41-733e-4989-b66e-21ee577b4827?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "(1,22 mg + 30 mg)/g",
"packaging": "05909990423712 ¦ Rp ¦ 13505\n1 tuba 15 g",
"substance": "Betamethasoni valeras 1.22 mg/g + Clioquinolum 30 mg/g",
"common_name": "Betamethasoni valeras + Clioquinolum",
"pl_product_id": "100087363",
"pozwolenie_nr": "04237",
"auth_procedure": "NAR",
"authorisation_validity": "2025-04-17"
}See everything about betamethason und antiseptika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.